Ident. | Authors (with country if any) | Title |
---|
000897 |
Jemma O'Connor [Royaume-Uni] ; Michael J. Vjecha [États-Unis] ; Andrew N. Phillips [Royaume-Uni] ; Brian Angus [Royaume-Uni] ; David Cooper [Australie] ; Beatriz Grinsztejn [Brésil] ; Gustavo Lopardo [Argentine] ; Satyajit Das [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Aimee Wilkin [États-Unis] ; Hartwig Klinker [Allemagne] ; Pacharee Kantipong [Thaïlande] ; Karin L. Klingman [États-Unis] ; David Jilich [République tchèque] ; Elbushra Herieka [Royaume-Uni] ; Eileen Denning [États-Unis] ; Ibrahim Abubakar [Royaume-Uni] ; Fred Gordin [États-Unis] ; Jens D. Lundgren [Danemark] | Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. |
001E84 |
Joseph N. Jarvis [Royaume-Uni] ; Tihana Bicanic ; Angela Loyse ; Daniel Namarika ; Arthur Jackson ; Jesse C. Nussbaum ; Nicky Longley ; Conrad Muzoora ; Jacob Phulusa ; Kabanda Taseera ; Creto Kanyembe ; Douglas Wilson ; Mina C. Hosseinipour ; Annemarie E. Brouwer ; Direk Limmathurotsakul ; Nicholas White ; Charles Van Der Horst ; Robin Wood ; Graeme Meintjes ; John Bradley ; Shabbar Jaffar ; Thomas Harrison | Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. |
002611 |
Darshini Govindasamy [Afrique du Sud] ; Katharina Kranzer [Afrique du Sud, Royaume-Uni] ; Nienke Van Schaik [Afrique du Sud] ; Farzad Noubary [États-Unis] ; Robin Wood [Afrique du Sud] ; Rochelle P. Walensky [États-Unis] ; Kenneth A. Freedberg [États-Unis] ; Ingrid V. Bassett [États-Unis] ; Linda-Gail Bekker [Afrique du Sud] | Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa |
002972 |
Joseph N. Jarvis [Royaume-Uni] ; Thomas S. Harrison ; Stephen D. Lawn ; Graeme Meintjes ; Robin Wood ; Susan Cleary | Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. |
002B50 |
Sophia Pathai [Royaume-Uni, Afrique du Sud] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Clare E. Gilbert [Royaume-Uni] ; Dagmara Mcguinness [Royaume-Uni] ; Liane Mcglynn [Royaume-Uni] ; Helen A. Weiss [Royaume-Uni] ; Jennifer Port [Royaume-Uni] ; Theresa Christ [Royaume-Uni] ; Karen Barclay [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Paul G. Shiels [Royaume-Uni] | Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study |
003062 |
Janne Estill [Suisse] ; Matthias Egger [Suisse] ; Nello Blaser [Suisse] ; Luisa Salazar Vizcaya [Suisse] ; Daniela Garone [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Jennifer Campbell [États-Unis] ; Timothy B. Hallett [Royaume-Uni] ; Olivia Keiser [Suisse] | Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study |
003097 |
Ankur Gupta [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Richard Kaplan [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Stephen D. Lawn [Royaume-Uni, Afrique du Sud] | Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community |
003490 |
Mweete D. Nglazi [Afrique du Sud, France] ; Nienke Van Schaik [Afrique du Sud] ; Katharina Kranzer [Royaume-Uni] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] | An incentivized HIV counseling and testing program targeting hard-to-reach unemployed men in Cape Town, South Africa |
003A06 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Anthony D. Harries [Royaume-Uni, France] ; Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Haileyesus Getahun [Suisse] ; Diane V. Havlir [États-Unis] ; Robin Wood [Afrique du Sud] | Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa |
003B07 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] | Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis |
004B00 |
Keren Middelkoop [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Landon Myer [Afrique du Sud, États-Unis] ; Andrew Whitelaw [Afrique du Sud] ; Alison Grant [Royaume-Uni] ; Gilla Kaplan [États-Unis] ; James Mcintyre [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Antiretroviral Program Associated with Reduction in Untreated Prevalent Tuberculosis in a South African Township |
004C32 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; David J. Edwards [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Reducing the Burden of Tuberculosis Presenting during the Initial Months of Antiretroviral Therapy in Resource-Limited Settings |
004D33 |
Joseph N. Jarvis [Afrique du Sud, Royaume-Uni] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Thomas S. Harrison [Afrique du Sud, Royaume-Uni] | Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action |
005225 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Landon Myer [Afrique du Sud, États-Unis] ; David Edwards [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa |
005367 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Francesca Little [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Richard Kaplan [Afrique du Sud] ; Elizabeth Campbel [Afrique du Sud] ; Catherine Orrell [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa |
005387 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Katharina Kranzer [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] | Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings |
005416 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; David Edwards [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] | Tuberculosis Transmission from Patients with Smear-Negative Pulmonary Tuberculosis in Sub-Saharan Africa |
005434 |
Joseph N. Jarvis [Afrique du Sud, Royaume-Uni] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Monica Vogt [Afrique du Sud] ; Nonzwakazi Bangani [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Thomas S. Harrison [Afrique du Sud, Royaume-Uni] | Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa |
005437 |
Joseph N. Jarvis [Afrique du Sud, Royaume-Uni] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Thomas S. Harrison [Afrique du Sud] | Reducing Mortality Associated with Opportunistic Infections among Patients with Advanced HIV Infection in Sub-Saharan Africa: Reply to DiNubile |
005B46 |
Motasim Badri [Afrique du Sud] ; Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] | Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting |
006364 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Anthony D. Harries [Royaume-Uni, Malawi] ; Xavier Anglaret [Côte d'Ivoire, France] ; Landon Myer [Afrique du Sud, États-Unis] ; Robin Wood [Afrique du Sud] | Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa |
006445 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Landon Myer [Afrique du Sud, États-Unis] ; Nonzwakazi Bangani [Afrique du Sud] ; Monica Vogt [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa |
006570 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Richard Kaplan [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] | Promoting Retention in Care: An Effective Model in an Antiretroviral Treatment Service in South Africa |
006C74 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Landon Myer [Afrique du Sud, États-Unis] ; Linda-Gail Bekker [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Tuberculosis-associated immune reconstitution disease : incidence, risk factors and impact in an antiretroviral treatment service in South Africa |
006E09 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Landon Myer [Afrique du Sud, États-Unis] ; Linda-Gail Bekker [Afrique du Sud] ; Robin Wood [Afrique du Sud] | CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa |
006E74 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Linda-Gail Bekker [Afrique du Sud] ; Keren Middelkoop [Afrique du Sud] ; Landon Myer [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Impact of HIV Infection on the Epidemiology of Tuberculosis in a Peri-Urban Community in South Africa: The Need for Age-Specific Interventions |
006E75 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] | Impact of Antituberculosis Treatment on Virological Response to Highly Active Antiretroviral Therapy: Implications for Resource-Limited Settings? |
007317 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Robin Wood [Afrique du Sud] | The epidemic of HIV-associated tuberculosis in sub-Saharan Africa : does this also impact non-HIV-infected individuals? |
007345 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Landon Myer [Afrique du Sud, États-Unis] ; Linda-Gail Bekker [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa : impact on treatment outcomes and implications for tuberculosis control |
007475 |
Stephen D. Lawn [Afrique du Sud, Royaume-Uni] ; Landon Myer [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Efficacy of Antiretroviral Therapy in Resource-Poor Settings: Are Outcomes Comparable to Those in the Developed World? |